Controlled ovarian hyperstimulation for assisted reproduction in infertility
Adult: As an adjunct to inhibit premature luteinising hormone surges: 250 mcg once daily during the mid to late portion of the follicular phase (e.g. day 5 or 6) after initiating FSH on day 2 or 3 of the menstrual cycle. Initiation of treatment may be delayed in the absence of follicular growth. Treatment should be continued daily until the day of hCG administration. Refer to detailed product guidelines for the specific instructions on administration, timing of inj, and duration of use.